Yasunori Yamamoto

Dr. Yasunori Yamamoto

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Nutrition
Verified
Journal Article
Closed access
Yoshihiro MiyakeYoshihiro Miyake
Yoshihiro Miyake
KTKeiko Tanaka
Keiko Tanaka
CNChisato Nagata
Chisato Nagata
Shinya FurukawaShinya Furukawa
Shinya Furukawa
AAAkira Andoh
Akira Andoh
YHYoichi Hiasa
Yoichi Hiasa

4 May 2021 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
Shinya FurukawaShinya Furukawa
Shinya Furukawa
YYYasunori Yamamoto
Yasunori Yamamoto
JWJunichi Watanabe
Junichi Watanabe
AKAki Kato
Aki Kato
KKKatsunori Kusumoto
Katsunori Kusumoto
YHYoichi Hiasa
Yoichi Hiasa

12 October 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
TKTeru Kumagi
Teru Kumagi
Shinya FurukawaShinya Furukawa
Shinya Furukawa
Bunzo MatsuuraBunzo Matsuura
Bunzo Matsuura
OYOsamu Yoshida
Osamu Yoshida
MMMasumi Miyazaki
Masumi Miyazaki
YHYoichi Hiasa
Yoichi Hiasa
The relationship between advanced nonalcoholic steatohepatitis (NASH) and plasma fatty acid composition remains unknown. We aimed to examine the plasma fatty acid composition in biopsy-confirmed nonalcoholic fatty liver disease (NAFLD) and evaluate the relationship between histological findings and fatty acid composition. Overall, 235 patients (134 women) with NAFLD were enrolled. Comprehensive blood chemistry tests and histological examinations of liver samples were conducted. Multivariate analyses adjusted for age, sex, body mass index, alanine aminotransferase, hemoglobin A1c, creatinine, total cholesterol, triglyceride, and NAFLD Activity Score values showed that lower levels of arachidic, behenic, α-linolenic, eicosatetraenoic, docosapentaenoic, and docosahexaenoic acids and higher levels of mead acid were associated with fibrosis stage 3–4. Furthermore, higher lauric acid, myristic acid, and palmitic acid levels and monounsaturated fatty acids such as palmitoleic acid and oleic acid were significantly associated with high NAS in analyses adjusted for the same factors and fibrosis stage. The plasma fatty acid composition was associated with the histological evidence of NASH. Increased synthesis of fatty acids is associated with NASH; insufficient intake of n-3 essential fatty acids and reduced elongation of fatty acids are associated with fibrosis in NASH. These features may help clinicians to understand and treat advanced NASH cases.

1 November 2021 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
Shinya FurukawaShinya Furukawa
Shinya Furukawa
YIYoshio Ikeda
Yoshio Ikeda
SYSen Yagi
Sen Yagi
TMTeruki Miyake
Teruki Miyake
KSKana Shiraishi
Kana Shiraishi
YHYoichi Hiasa
Yoichi Hiasa
INTRODUCTION: Monocytes play an important role in innate immunity. Some epidemiological evidence indicates an association between peripheral blood monocytes and ulcerative colitis (UC). The association between peripheral blood monocytes and mucosal healing (MH), however, remains unclear. We evaluated this issue in patients with UC. METHODS: Study subjects consisted of 272 Japanese patients with UC. Monocyte counts were taken in the morning after overnight fasting. Monocyte count was divided into tertiles based on the distribution of values among all study subjects. Information on clinical remission was obtained from medical records. MH was assessed using the Mayo endoscopic subscore. RESULTS: The mean monocyte count was 360.1 ± 155.3/mm3. Rates of clinical remission, MH, and complete MH were 61.0%, 66.2%, and 27.9%, respectively. High monocyte count was significantly inversely associated with clinical remission, MH, and complete MH (adjusted odds ratio [OR] 0.45 [95% confidence interval [CI]: 0.23–0.89], OR 0.45 [95% CI: 0.23–0.89], and OR 0.48 [95% CI: 0.23–0.97], respectively). Patients were also classified according to C-reactive protein (CRP) levels; in the low CRP group (<0.1 mg/dL), high monocyte count was independently inversely associated with complete MH but not with clinical remission or MH (OR 0.33 [95% CI: 0.10–0.92], P for trend = 0.027). In the high CRP group, there was no association between monocyte count and clinical outcomes. DISCUSSION: Our findings suggest that peripheral blood monocyte count can be used as a serum supplemental marker for MH in UC patients with low CRP levels.

29 October 2011 in Breast Cancer
Verified
Journal Article
Closed access
PDF file
YOYukako Ohno
Yukako Ohno
Masakuni NoguchiMasakuni Noguchi
Masakuni Noguchi
MYMiki Yokoi-Noguchi
Miki Yokoi-Noguchi
YNYasuharu Nakano
Yasuharu Nakano
KSKen-Ichi Shimada
Ken-Ichi Shimada
SKShigehiko Kawakami
Shigehiko Kawakami

7 October 2021 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
YYYasunori Yamamoto
Yasunori Yamamoto
Shinya FurukawaShinya Furukawa
Shinya Furukawa
JWJunichi Watanabe
Junichi Watanabe
AKAki Kato
Aki Kato
KKKatsunori Kusumoto
Katsunori Kusumoto
YHYoichi Hiasa
Yoichi Hiasa